Generics
Henlius and Sandoz expand biosimilars collaboration
17 August 2026 - Shanghai-based biopharmaceutical company Shanghai Henlius Biotech, Inc. (HKG: 2696) said on Monday it has agreed a strategic collaboration with generic biosimilars company Sandoz Grou...
Aurisco Pharmaceutical reports successful US FDA inspection
13 August 2026 - Oligonucleotide and peptide (TIDES) manufacturer Aurisco Pharmaceutical Co Ltd (SSE:605116) announced on Wednesday that its site in Yangzhou, China has passed US FDA inspection as the...
Dr. Reddy's launches first-to-market sugammadex injection in the US
4 August 2026 - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd (BSE:500124, NSE:DRREDDY, NYSE:RDY) announced on Tuesday that it has launched Sugammadex Injection 200 mg/2 mL and 500 m...
DifGen Pharmaceuticals' single injection treatment for advanced breast cancer cleared for clinical development
28 July 2026 - Generic pharmaceuticals manufacturer DifGen Pharmaceuticals LLC announced on Monday that the US Food and Drug Administration (FDA) has accepted the company's Investigational New Dr...
Par Health launches generic version of Janumet XR tablets in US
27 July 2026 - US pharmaceutical company Par Health Inc announced on Friday the launch of its generic version of Merck's Janumet XR (sitagliptin and metformin HCl extended-release) tablets for or...
EQL Pharma gains approval to sell Mellozzan in Kazakhstan
15 July 2026 - Swedish pharmaceutical company EQL Pharma AB (STO: EQL), which specialises in developing and selling generics, said on Wednesday it has secured approval for its melatonin-based product ...